Natural Gas Plunges to a 3.5 Year Low, Will Prices Continue to Fall?

The market expected a 100 bcf withdrawal Ten weeks left until the 2020 injection season The price sits at a low level   After falling to a low of $2.083 per MMBtu on the nearby February NYMEX futures contract on January 3, the price of natural gas has been crawling higher. The price reached its latest peak of $2.255 on January 14. Natural gas has traded at its lowest mid-winter prices since 2016 on a combination of bearish sentiment in the futures and stockpiles that are appreciably above last year…

What Does A Phase 1 Deal Mean For Stocks & Commodities?

U.S. and China trade representatives are set to complete a saga of fierce bilateral negotiations on Wednesday with a “Phase One” deal that asserts billions of dollars’ worth of agricultural purchases and the start of reforms to China’s ongoing practice of compulsory technology transfer. The trade deal, which had reached an impasse around Thanksgiving, raised fears that an accord would collapse again, dragging stocks and hopes for a halt to the nearly two-year-old trade war with it. But then just days later, President Trump announced that a deal would be…

Homebuilders ETFs: Housing Starts Hit 13-Year High

Homebuilder sector exchange traded funds are building on the improving housing market recovery as U.S. home construction jumped to a 13-year high in December. Over the past year, the SPDR S&P Homebuilders ETF (NYSEArca: XHB) increased 38.5%, iShares U.S. Home Construction ETF (NYSEArca: ITB) gained 45.5% and Invesco Dynamic Building & Construction ETF (NYSEArca: PKB) advanced 41.2%. The homebuilding sector is strengthening across the board, with housing starts up 16.9% to a seasonally adjusted annual rate of 1.608 million units in December, the highest level since December 2006, Reuters reports.…

Why are Shares of GW Pharmaceuticals (GWPH) Up 15% in 2020?

GW Pharmaceuticals PLC (GWPH) stocks rallied this week after the company released preliminary Q4 results that exceeded forecasts. The driving force behind the GWPH’s performance came from better-than-expected sales of the company’s flagship product Epidiolex, the cannabidiol (CBD)-based drug used to treat epilepsy, Lennox-Gastaut and Dravet syndromes.  Thus far, Epidiolex is the only CBD-based pharmaceutical approved by the FDA. Of the company’s $108 million in fourth quarter sales, $104 million of that came from Epidiolex sales. GW Pharmaceuticals expects to report $309 million in revenue for the entire year, exceeding…

Day Hagan / Ned Davis Release Smart Sector ETF ‘SSUS’

On Friday, Day Hagan Asset Management (DH) and Ned Davis Research (NDR), a leading independent provider of global economic and financial analysis, launched a new ETF looking towards long-term appreciation and preservation. The Day Hagan/Ned Davis Research Smart Sector ETF (SSUS) is designed to seek long-term capital appreciation and preservation of capital. A proactive, adaptive strategy, SSUS is incorporated in the U.S. and considered a “fund of funds” that, under normal market conditions, seeks to achieve its investment objective by principally investing in unaffiliated equity ETFs that track the performance…